Varian, a Siemens Healthineers company, today announced the launch of HyperSight™ imaging solution for its TrueBeam and Edge systems across the Asia Pacific region (excluding China). This upgrade gives clinicians unparalleled image quality, enhancing their ability to deliver precise and efficient radiation therapy treatments.

西门子Healthineers公司Varian今天宣布在亚太地区（不包括中国）为其TrueBeam和Edge系统推出HyperSight™成像解决方案。这一升级为临床医生提供了无与伦比的图像质量，增强了他们提供精确有效放射治疗的能力。

HyperSight optimizes workflows across Varian’s entire suite of linear accelerators, enabling more tailored treatment for each patient..

HyperSight优化了瓦里安全套直线加速器的工作流程，为每位患者提供了更具针对性的治疗。。

HyperSight acquires high-quality images and offers an extended field of view during a patient's daily radiation treatments, which is particularly beneficial for treating large cancers. This facilitates accurate tumor volume targeting, reduces target volume margins, and preserves healthy tissue. It provides Hounsfield Unit (HU) accuracy needed for treatment planning directly on the acquired conebeam CT (CBCT) images, allowing clinicians to calculate changes in tumors and surrounding organs with greater precision, helping to adjust treatments more effectively.

HyperSight可以获得高质量的图像，并在患者日常放射治疗期间提供扩展的视野，这对治疗大型癌症特别有益。这有助于准确的肿瘤体积靶向，减少目标体积边缘，并保留健康组织。它直接在获取的conebeam CT（CBCT）图像上提供治疗计划所需的Hounsfield单位（HU）准确性，使临床医生能够更精确地计算肿瘤和周围器官的变化，有助于更有效地调整治疗。

This eliminates the need for separate CT scans, potentially avoiding extensions to a patient’s hospital stay. HyperSight is designed for all anatomical sites and has a 50% faster gantry rotation compared to traditional CBCT scans, which can take up to 60 seconds. For existing TrueBeam and Edge users, the upgrade seamlessly integrates with their systems, reducing motion-related artifacts due to patient movement and minimizing discomfort from prolonged treatment times..

这消除了对单独CT扫描的需要，可能避免延长患者的住院时间。HyperSight适用于所有解剖部位，与传统的CBCT扫描相比，机架旋转速度快50%，最多需要60秒。对于现有的TrueBeam和Edge用户，该升级与他们的系统无缝集成，减少了由于患者移动而产生的与运动相关的伪影，并最大程度地减少了延长治疗时间带来的不适感。。

The Asia Pacific region is facing a growing radiotherapy demand, with clinicians burdened by increased patient volumes and limited access to advanced technologies1. Varian is committed to supporting healthcare providers with an innovative portfolio of radiotherapy solutions, including HyperSight, and is working with regulators to review reimbursement models to support optimal patient care..

亚太地区面临着日益增长的放射治疗需求，临床医生面临着患者数量增加和先进技术获取有限的负担1。瓦里安致力于为医疗保健提供者提供创新的放射治疗解决方案组合，包括HyperSight，并与监管机构合作审查报销模式，以支持最佳的患者护理。。

At the recent ESTRO meets Asia conference, Dr. Sujith Baliga, Associate Professor, Department of Radiation Oncology, The Ohio State University Wexner Medical Center, shared his experience with the HyperSight upgrade to TrueBeam: “HyperSight has been instrumental in improving our workflow and boosting our confidence in imaging and treatment.

在最近的ESTRO meets Asia会议上，俄亥俄州立大学韦克斯纳医学中心放射肿瘤学系副教授Sujith Baliga博士分享了他将HyperSight升级到TrueBeam的经验：“HyperSight有助于改进我们的工作流程，增强我们对成像和治疗的信心。

Previously, we were limited in the precision and speed of imaging. Now, we can significantly reduce inefficiencies in our workflow and focus on enhancing patient comfort and delivering optimal care.”.

以前，我们在成像的精度和速度方面受到限制。。

'We are excited to introduce HyperSight imaging to our TrueBeam and Edge platform in the Asia Pacific region, marking a major step in advanced radiotherapy treatment,' said Hideaki Mori, President of Varian APJ. 'Guided by the evolving needs of radiation therapy based on current clinical trends, this innovation exemplifies our commitment to advancing clinical practice and providing high quality solutions for cancer patients everywhere.

瓦里安APJ总裁Hideaki Mori说：“我们很高兴在亚太地区的TrueBeam和Edge平台上引入HyperSight成像，这标志着先进放射治疗迈出了重要一步。”在基于当前临床趋势的放射治疗不断发展的需求的指导下，这项创新体现了我们对推进临床实践和为各地癌症患者提供高质量解决方案的承诺。

By combining advanced imaging with precise treatment delivery, we empower clinicians to deliver superior care.'.

通过将先进的成像技术与精确的治疗相结合，我们使临床医生能够提供优质的护理。”。

The statement by Varian's customer described above is based on results achieved in the customer's unique clinical setting. Because there is no 'typical' clinical setting and many variables exist, there is no guarantee that other customers will achieve the same results.

上述瓦里安客户的声明是基于在客户独特的临床环境中取得的结果。由于没有“典型”的临床环境，并且存在许多变量，因此无法保证其他客户会获得相同的结果。

VARIAN, HYPERSIGHT, ETHOS, and HALCYON are trademarks of Varian Medical Systems, Inc., pending or registered U.S. Pat. & Tm. Off.

VARIAN、HYPERSIGHT、ETHOS和HALCYON是VARIAN Medical Systems，Inc.的商标，正在申请或注册美国专利Tm关闭。

About Varian

关于瓦里安

At Varian, a Siemens Healthineers company, we envision a world without fear of cancer. For more than 75 years, Varian has developed, built, and delivered innovative technologies and solutions that help care providers around the globe treat millions of patients each year. Today, as a Siemens Healthineers company, we support every step of the cancer care journey – from screening to survivorship.

在西门子Healthineers公司Varian，我们设想一个没有癌症恐惧的世界。75多年来，瓦里安开发、制造并提供了创新技术和解决方案，帮助全球护理提供者每年治疗数百万患者。今天，作为西门子Healthineers公司，我们支持癌症护理旅程的每一步，从筛查到生存。

From advanced imaging and radiation therapy to comprehensive software and services, to interventional radiology, we are harnessing the power of our perspective while also pursuing clinical research to create a more efficient, and more personalized care pathway. Because, for cancer patients everywhere, their fight is our fight.

从先进的成像和放射治疗到全面的软件和服务，再到介入放射学，我们正在利用我们的观点的力量，同时也在进行临床研究，以创建更高效，更个性化的护理途径。因为，对于世界各地的癌症患者来说，他们的斗争就是我们的斗争。